BRPI0411707A - preparação de 1,2,3-triazóis n2-alquilados - Google Patents

preparação de 1,2,3-triazóis n2-alquilados

Info

Publication number
BRPI0411707A
BRPI0411707A BRPI0411707-7A BRPI0411707A BRPI0411707A BR PI0411707 A BRPI0411707 A BR PI0411707A BR PI0411707 A BRPI0411707 A BR PI0411707A BR PI0411707 A BRPI0411707 A BR PI0411707A
Authority
BR
Brazil
Prior art keywords
preparation
alkylated
triazoles
phenyl
triazols
Prior art date
Application number
BRPI0411707-7A
Other languages
English (en)
Inventor
Mark Allen Hadd
Brian Joseph Nichelson
Zhijian Zhu
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BRPI0411707A publication Critical patent/BRPI0411707A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"PREPARAçãO DE 1,2,3-TRIAZóIS N2-ALQUILADOS". Esta invenção revela métodos e materiais para a preparação de triazóis N2-alquilados, tais como o ácido 3-{4-¢3-(5-metil-2-fenil-oxazol-4-il)-propill-fenil}-2-¢1,2,3!triazol-2-il-propi ónico. Tais compostos são agonistas dos PPAR que são úteis para o tratamento da diabetes não-insulinodependente.
BRPI0411707-7A 2003-06-27 2004-06-15 preparação de 1,2,3-triazóis n2-alquilados BRPI0411707A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48343203P 2003-06-27 2003-06-27
PCT/IB2004/002058 WO2005000841A1 (en) 2003-06-27 2004-06-15 Preparation of n2-alkylated 1,2,3-triazoles

Publications (1)

Publication Number Publication Date
BRPI0411707A true BRPI0411707A (pt) 2006-08-08

Family

ID=33552060

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411707-7A BRPI0411707A (pt) 2003-06-27 2004-06-15 preparação de 1,2,3-triazóis n2-alquilados

Country Status (7)

Country Link
US (1) US20040266848A1 (pt)
EP (1) EP1641788A1 (pt)
JP (1) JP2007516171A (pt)
BR (1) BRPI0411707A (pt)
CA (1) CA2529109A1 (pt)
MX (1) MXPA05013579A (pt)
WO (1) WO2005000841A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007023018A1 (de) * 2005-07-13 2007-03-01 Basf Aktiengesellschaft 7-amino-6-triazolyl-1,2,4-triazolo[1,5-a]pyrimidin-verbindungen und ihre verwendung zur bekämpfung von schadpilzen
CN112004803B (zh) * 2018-04-23 2023-11-03 科赛普特治疗公司 区域选择的n-烷基三唑的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5759757A (en) * 1996-10-17 1998-06-02 Eastman Kodak Company Photographic elements containing development inhibitor releasing compounds
US20030171377A1 (en) * 2001-08-29 2003-09-11 Bigge Christopher Franklin Antidiabetic agents
KR20040044515A (ko) * 2001-08-29 2004-05-28 워너-램버트 캄파니 엘엘씨 경구용 항당뇨병제

Also Published As

Publication number Publication date
CA2529109A1 (en) 2005-01-06
WO2005000841A1 (en) 2005-01-06
WO2005000841A8 (en) 2005-03-31
EP1641788A1 (en) 2006-04-05
JP2007516171A (ja) 2007-06-21
MXPA05013579A (es) 2006-03-09
US20040266848A1 (en) 2004-12-30

Similar Documents

Publication Publication Date Title
ATE526318T1 (de) Farnesoid-x-rezeptor-agonisten
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
ATE433447T1 (de) Pyrimiidinverbindungen
BRPI0418149A (pt) derivados heterocìclicos como agonistas do receptor de gprc
ID18883A (id) Pesaing 5-ht 1f
CY1106467T1 (el) Ελεγχομενη συνθεση ζιπρασιδονης
JO2578B1 (en) Compounds Theophene benzimidazole
ATE410430T1 (de) 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
EA200301213A1 (ru) Лиганды рецепторов 5-ht и их применение
MY143599A (en) Pyrazole derivatives, compositions containing such compounds and methods of use
ATE449604T1 (de) Pyrazolamid-derivate, diese verbindungen enthaltende zusammensetzungen und anwendungsverfahren
DE602004007693D1 (de) (3-oxo-3,4-dihydro-chinoxalin-2-yl-amino)-benzamid-derivate und verwandte verbindungen als glykogen-phosphorylase-hemmer zur behandlung von diabetes und adipositas
CL2007002890A1 (es) Compuestos derivados de 2-piridincarboxamida, activador de glucosinasa; composicion farmaceutica; y uso del compuesto para el tratamiento de diabetes o la obesidad.
AR055570A1 (es) Polimorfo de oxazol - pirrolidina, procesos de obtencion y composiciones farmaceuticas.
TR200103119T2 (tr) Göz kurumasının tedavisi için madde.
CL2007002388A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de hemangiomas o hemangioblastomas.
EA200800927A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ
YU76902A (sh) Upotreba bradikardijskih supstanci u lečenju miokardnih oboljenja povezanih sa hipertrofijom i nove koombinacije lekova
ES2166046T3 (es) Derivados de arilacrilamida como agonistas o antagonistas de 5ht1.
ATE459620T1 (de) Benzimidazolthiophenverbindungen als plk- modulatoren
MXPA05008960A (es) Oxazolidinonas de indolona antibacteriales, intermedios para su preparacion y composiciones farmaceuticas que las contienen.
AU2003294253A8 (en) Emulsions including surface-modified organic molecules
WO2001087287A3 (en) Use of pyrazole derivatives for treating infertility
TR199901017A2 (xx) B�cek ilac� terkibi.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired